Zedaf Rosenberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IPM’s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration IPM’s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration SILVER SPRING, Md. (March 3, 2021)—The nonprofit International Partnership for Microbicides (IPM) announced today that the US Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the monthly dapivirine vaginal ring, designed to reduce the risk of HIV-1 infection through vaginal...

IPM Welcomes WHO’s Recommendation for Dapivirine Vaginal Ring as New Women’s HIV Prevention Option IPM Welcomes WHO’s Recommendation for Dapivirine Vaginal Ring as New Women’s HIV Prevention Option WHO recommends the monthly ring be offered as part of a combination prevention approach for women at substantial HIV risk SILVER SPRING, Md. (January 27, 2021)—The nonprofit International Partnership for Microbicides (IPM) welcomes today’s recommendation by the World Health Organization (WHO) that the monthly dapivirine ring may be offered as an additional prevention choice for women at...